We examined the percentage of TIM-3 positivity and the activation status (via CD69 and IFNγ) following the PMA and ionomycin stimulation of glioblastoma patients’ T and NK cells compared to those of healthy individuals. This evidence concerns the gene CD69 and glioblastoma.